- Client News
Geneva Health Solutions launches Geneva University
Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, has formalized…
News
- Client News
Murano Connect results in $10 billion to fund managers
Murano Connect, a leading financial services company that matches fund managers to allocators, today announced it has sourced opportunities that…
- Client News
TaskUs' Jaspar Weir on the power of annual reviews
According to TaskUs’ CEO and President Jaspar Weir, some of the biggest complaints in corporate culture are employee performance reviews…
- Client News
CrowdOut's Alexander Schoenbaum talks to Tearsheet about the future of lending in 2019 and beyond
Tearsheet asked some of the top experts in online lending, including CrowdOut’s Alexander Schoenbaum, to describe what they feel are…
- Client News
CURE Pharmaceutical and CUREfilm featured on Drug Development & Delivery
The actual design and construction of an oral film capable of effective therapeutic delivery can be challenging and requires the…
- Client News
The four questions to ask before choosing a financial advisor, according to Lido Advisors' Greg Kushner
As the senior managing director of a financial advisory firm, Lido Advisors’ Greg Kushner knows there’s no such thing as…
- Client News
USC Marshall releases "Buying Beauty for the Long Run"
Scientists from USC Marshall conducted a study to see what kind of effect a gadget’s color had on its long-term…
- Client News
CompoSecure manufactures one million dual interface premium cards
CompoSecure, L.L.C., a pioneer and global leader in the design and manufacturing of premium financial cards, today announced that it…
- Client News
EpicGenetics and Massachusetts General Hospital to launch fibromyalgia clinical trial
The FM/a Test, a clinical diagnostic blood test which is performed by Los Angeles-based EpicGenetics, has been approved for use by…
- Client News
CURE Pharmaceutical joins forces with Canopy Growth in exclusive partnership
CURE Pharmaceutical has signed a deal with Canopy Growth Corp (TSX:WEED, NYSE:CGC), where Canopy will have an exclusive license to…